The discovery that patients have antibodies against the astrocyte water channel aquaporin-4 (AQP4) helped distinguish NMO patients from those with multiple sclerosis36–38, and these antibodies are now a central part of NMO diagnosis39. Here, AQP4 is linked to neuromyelitis optica.